Effect of Donepezil and Memantine on improving cognitive functio
Not Applicable
Recruiting
- Conditions
- Temporal lobe epilepsy.Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
- Registration Number
- IRCT20180113038344N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Having age between 18-55 years
Having temporal lobe epilepsy
Have no other neurological disease
Use no medications for treating cognitive disorders
willingness to participate in this study
Exclusion Criteria
Having mental retardation
Having progressive neurological disease
Having sensitivity to Memantine or Donepezil
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The score of Montreal Cognitive Assessment test. Timepoint: Before and immediately after intervention. Method of measurement: Montreal Cognitive Assessment questionnaire.
- Secondary Outcome Measures
Name Time Method Incidence of sensitivity to Memantine. Timepoint: During intervention. Method of measurement: observation.;Incidence of sensitivity to Donepezil. Timepoint: During intervention. Method of measurement: observation.